AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (May 9, 2003). doi:10.1152/ajplung.00284.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/3/L740    most recent
00284.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, S.
Right arrow Articles by Yuan, J. X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, S.
Right arrow Articles by Yuan, J. X.-J.
Submitted on August 16, 2002
Accepted on April 28, 2003

Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells

Shen Zhang1, Ivana Fantozzi1, Donna D. Tigno1, Eunhee S. Yi2, Oleksandr Platoshyn1, Patricia A. Thistlethwaite3, Jolene M. Kriett3, Gordon Yung1, Lewis J. Rubin1, and Jason X.-J. Yuan1*

1 Department of Medicine, University of California, San Diego, San Diego, CA, USA
2 Department of Pathology, University of California, San Diego, San Diego, CA, USA
3 Department of Surgery, University of California, San Diego, San Diego, CA, USA

* To whom correspondence should be addressed. E-mail: xiyuan{at}ucsd.edu.

Pulmonary vascular medial hypertrophy in primary pulmonary hypertension (PPH) is mainly caused by increased proliferation and decreased apoptosis in pulmonary artery smooth muscle cells (PASMC). Mutations of the bone morphogenetic protein (BMP) receptor type II (BMP-RII) gene have been implicated in patients with familial and sporadic PPH. The objective of this study was to elucidate apoptotic effects of BMPs on normal human PASMC and to examine whether BMPinduced effect is altered in PASMC from PPH patients. Using RT-PCR, we detected 6 isoforms of BMPs, BMP1-6, and three subunits of BMP receptors, BMP-RIa, -RIb and -RII in PASMC. Treatment of normal PASMC with BMP2 or BMP7 (100-200 nM, 24-48 hrs) markedly increased percentage of the cells undergoing apoptosis. The BMP2-mediated apoptosis in normal PASMC was associated with a transient activation or phosphorylation of Smad1 and with a marked downregulation of Bcl-2, an antiapoptotic protein. In PASMC from PPH patients, the BMP2- or BMP7-induced apoptosis was significantly inhibited in comparison to PASMC from patients with secondary pulmonary hypertension. These results suggest that the antiproliferative effect of BMPs is partially due to induction of PASMC apoptosis, which serves as a critical mechanism to maintain normal cell number in the pulmonary vasculature. Inhibition of BMP-induced PASMC apoptosis in PPH patients may play an important role in the development of pulmonary vascular medial hypertrophy in these patients.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
L. J. Rubin
BMPR2 Mutation and Outcome in Pulmonary Arterial Hypertension: Clinical Relevance to Physicians and Patients
Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1300 - 1301.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais, O. Sitbon, D. Montani, R. Souza, G. Simonneau, F. Soubrier, et al.
Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation
Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1377 - 1383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. B. Ray, S. Arab, Y. Deng, P. Liu, L. Penn, D. W. Courtman, and M. E. Ward
Oxygen regulation of arterial smooth muscle cell proliferation and survival
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H839 - H852.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Archer, M. Gomberg-Maitland, M. L. Maitland, S. Rich, J. G. N. Garcia, and E. K. Weir
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1{alpha}-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H570 - H578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. B. Frank, J. Lowery, L. Anderson, M. Brink, J. Reese, and M. de Caestecker
Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature
Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L98 - L109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Lagna, M. M. Ku, P. H. Nguyen, N. A. Neuman, B. N. Davis, and A. Hata
Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors
J. Biol. Chem., December 21, 2007; 282(51): 37244 - 37255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
X. Yang, P. J. Lee, L. Long, R. C. Trembath, and N. W. Morrell
BMP4 Induces HO-1 via a Smad-Independent, p38MAPK-Dependent Pathway in Pulmonary Artery Myocytes
Am. J. Respir. Cell Mol. Biol., November 1, 2007; 37(5): 598 - 605.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. C. Chan, P. H. Nguyen, B. N. Davis, N. Ohoka, H. Hayashi, K. Du, G. Lagna, and A. Hata
A Novel Regulatory Mechanism of the Bone Morphogenetic Protein (BMP) Signaling Pathway Involving the Carboxyl-Terminal Tail Domain of BMP Type II Receptor
Mol. Cell. Biol., August 15, 2007; 27(16): 5776 - 5789.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
O. Pak, A. Aldashev, D. Welsh, and A. Peacock
The effects of hypoxia on the cells of the pulmonary vasculature
Eur. Respir. J., August 1, 2007; 30(2): 364 - 372.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Zakrzewicz, M. Hecker, L. M. Marsh, G. Kwapiszewska, B. Nejman, L. Long, W. Seeger, R. T. Schermuly, N. W. Morrell, R. E. Morty, et al.
Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension
Circulation, June 12, 2007; 115(23): 2957 - 2968.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Zakrzewicz, F. M. Kouri, B. Nejman, G. Kwapiszewska, M. Hecker, R. Sandu, E. Dony, W. Seeger, R. T. Schermuly, O. Eickelberg, et al.
The transforming growth factor-{beta}/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
Eur. Respir. J., June 1, 2007; 29(6): 1094 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. E. Morty, B. Nejman, G. Kwapiszewska, M. Hecker, A. Zakrzewicz, F. M. Kouri, D. M. Peters, R. Dumitrascu, W. Seeger, P. Knaus, et al.
Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1072 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Zhang, H. H. Patel, F. Murray, C. V. Remillard, C. Schach, P. A. Thistlethwaite, Paul. A. Insel, and J. X.-J. Yuan
Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1202 - L1210.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
C. V. Remillard, D. D. Tigno, O. Platoshyn, E. D. Burg, E. E. Brevnova, D. Conger, A. Nicholson, B. K. Rana, R. N. Channick, L. J. Rubin, et al.
Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension
Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1837 - C1853.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. S. McMurtry, R. Moudgil, K. Hashimoto, S. Bonnet, E. D. Michelakis, and S. L. Archer
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L872 - L878.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
T. M. Bull, C. D. Coldren, M. W. Geraci, and N. F. Voelkel
Gene Expression Profiling in Pulmonary Hypertension
Proceedings of the ATS, January 1, 2007; 4(1): 117 - 120.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
N. W. Morrell
Pulmonary Hypertension Due to BMPR2 Mutation: A New Paradigm for Tissue Remodeling?
Proceedings of the ATS, November 1, 2006; 3(8): 680 - 686.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Lagna, P. H. Nguyen, W. Ni, and A. Hata
BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells.
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L1059 - L1067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Fantozzi, O. Platoshyn, A. H. Wong, S. Zhang, C. V. Remillard, M. R. Furtado, O. V. Petrauskene, and J. X.-J. Yuan
Bone morphogenetic protein-2 upregulates expression and function of voltage-gated K+ channels in human pulmonary artery smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L993 - L1004.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Rich
The current treatment of pulmonary arterial hypertension: time to redefine success.
Chest, October 1, 2006; 130(4): 1198 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
E. Gurbanov and X. Shiliang
The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.
Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Cogolludo, L. Moreno, F. Lodi, G. Frazziano, L. Cobeno, J. Tamargo, and F. Perez-Vizcaino
Serotonin Inhibits Voltage-Gated K+ Currents in Pulmonary Artery Smooth Muscle Cells: Role of 5-HT2A Receptors, Caveolin-1, and KV1.5 Channel Internalization
Circ. Res., April 14, 2006; 98(7): 931 - 938.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Takahashi, N. Goto, Y. Kojima, Y. Tsuda, Y. Morio, M. Muramatsu, and Y. Fukuchi
Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L450 - L458.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. D. Michelakis
Spatio-Temporal Diversity of Apoptosis Within the Vascular Wall in Pulmonary Arterial Hypertension: Heterogeneous BMP Signaling May Have Therapeutic Implications
Circ. Res., February 3, 2006; 98(2): 172 - 175.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. Teichert-Kuliszewska, M. J.B. Kutryk, M. A. Kuliszewski, G. Karoubi, D. W. Courtman, L. Zucco, J. Granton, and D. J. Stewart
Bone Morphogenetic Protein Receptor-2 Signaling Promotes Pulmonary Arterial Endothelial Cell Survival: Implications for Loss-of-Function Mutations in the Pathogenesis of Pulmonary Hypertension
Circ. Res., February 3, 2006; 98(2): 209 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Iwata, R. T. Cowling, D. Gurantz, C. Moore, S. Zhang, J. X.-J. Yuan, and B. H. Greenberg
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2356 - H2363.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Hruska, S. Mathew, and G. Saab
Bone Morphogenetic Proteins in Vascular Calcification
Circ. Res., July 22, 2005; 97(2): 105 - 114.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. J. Stewart
Bone Morphogenetic Protein Receptor-2 and Pulmonary Arterial Hypertension: Unraveling a Riddle Inside an Enigma?
Circ. Res., May 27, 2005; 96(10): 1033 - 1035.
[Full Text] [PDF]


Home page
Circ. Res.Home page
X. Yang, L. Long, M. Southwood, N. Rudarakanchana, P. D. Upton, T. K. Jeffery, C. Atkinson, H. Chen, R. C. Trembath, and N. W. Morrell
Dysfunctional Smad Signaling Contributes to Abnormal Smooth Muscle Cell Proliferation in Familial Pulmonary Arterial Hypertension
Circ. Res., May 27, 2005; 96(10): 1053 - 1063.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. X.-J. Yuan and L. J. Rubin
Pathogenesis of Pulmonary Arterial Hypertension: The Need for Multiple Hits
Circulation, February 8, 2005; 111(5): 534 - 538.
[Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Beppu, F. Ichinose, N. Kawai, R. C. Jones, P. B. Yu, W. M. Zapol, K. Miyazono, E. Li, and K. D. Bloch
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1241 - L1247.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. S. McMurtry, S. Bonnet, X. Wu, J. R.B. Dyck, A. Haromy, K. Hashimoto, and E. D. Michelakis
Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis
Circ. Res., October 15, 2004; 95(8): 830 - 840.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. E. Brevnova, O. Platoshyn, S. Zhang, and J. X.-J. Yuan
Overexpression of human KCNA5 increases IK(V) and enhances apoptosis
Am J Physiol Cell Physiol, September 1, 2004; 287(3): C715 - C722.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Rabinovitch
The Mouse Through the Looking Glass: A New Door Into the Pathophysiology of Pulmonary Hypertension
Circ. Res., April 30, 2004; 94(8): 1001 - 1004.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.